SKU:K1357 | M. Wt:525.56 | ||
Formula:C25H27F4N3O3S | Solubility:No | ||
Purity:>99% | Storage:2 years at -20 degrees centigrade | ||
CAS No.:603139-19-1 | Synonyms:N/A | ||
Chemical NameN/A |
供货周期: | 一周 |
品牌: | |
规格: | 2mg |
货号: | K1357 |
CAS号: | 603139-19-1 |
SKU:K1357 | M. Wt:525.56 | ||
Formula:C25H27F4N3O3S | Solubility:No | ||
Purity:>99% | Storage:2 years at -20 degrees centigrade | ||
CAS No.:603139-19-1 | Synonyms:N/A | ||
Chemical NameN/A |
Description | Odanacatib (MK 0822) | |||||
---|---|---|---|---|---|---|
Targets | N/A | |||||
IC50 | N/A | |||||
In vitro | Odanacatib is a potent, selective, and neutral cathepsin K inhibitor. Odanacatib is more selective in whole cell assays than the other Cat K inhibitors balicatib and relacatib. | |||||
In vivo | As an orally active, potent, and selective CatK inhibitor, odanacatib (ODN) exhibits robust and sustained suppression of bone resorption biomarkers (CTx and NTx/Cr) at weekly doses > or = 25 mg and daily doses > or = 2.5 mg. With the 50-mg dose of odanacatib, lumbar spine and total-hip BMD increased 5.5% and 3.2%, respectively, whereas BMD at these sites was essentially unchanged with placebo (-0.2% and -0.9%). | |||||
Clinical Trials | N/A | |||||
Features | N/A |
相关产品
重组人肌球蛋白轻链2(Recombinant Human MYL2)
重组大鼠抵抗素(Rat Resistin)
大鼠酸性磷酸酶(ACP)ELISA Kit
大鼠胆囊收缩素/缩胆囊素八肽(CCK-8)ELISA Kit
人瘦素(LEP)ELISA Kit
重组人半乳糖凝集素16/LGALS16 Human
重组人半乳糖凝集素8/Human LGALS8 His
重组人半乳糖凝集素3/Human LGALS3 His
重组人卵泡抑素/Human FST His
重组人β防御素118/DEFB118 Human
重组人心肌营养素1/CTF1 Human
特级新生牛血清(无支原体)
超级新生牛血清(无支原体)
优级胎牛血清(无支原体)
特级新生牛血清(无噬菌体低内毒素)
详细地址
关注
拨打电话
留言咨询